The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Peter Jüni
Showing 1-20 of 44 articles
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian A,
Praz F,
Milojevic M,
Baldus S,
Bauersachs J,
Capodanno D,
Conradi L,
De Bonis M,
De Paulis R,
Delgado V,
Freemantle N,
Haugaa K,
Jeppsson A,
Jüni P,
Pierard L,
Prendergast B,
Sádaba J,
Tribouilloy C,
Wojakowski W,
Beyersdorf F
February 4, 2022 | 10.4244/EIJ-E-21-00009
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
Piccolo R,
Oliva A,
Avvedimento M,
Franzone A,
Windecker S,
Valgimigli M,
Esposito G,
Jüni P
September 20, 2021 | 10.4244/EIJ-D-20-01197
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes
Franzone A,
McFadden E,
Leonardi S,
Piccolo R,
Vranckx P,
Serruys P,
Hamm C,
Steg G,
Heg D,
Branca M,
Jüni P,
Windecker S,
Valgimigli M
October 23, 2020 | 10.4244/EIJ-D-20-00145
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial
Tomaniak M,
Chichareon P,
Modolo R,
Takahashi K,
Chang C,
Kogame N,
Spitzer E,
Buszman P,
van Geuns R,
Valkov V,
Steinwender C,
Geisler T,
Prokopczuk J,
Sabaté M,
Zmudka K,
Rademaker-Havinga T,
Tijssen J,
Jüni P,
Hamm C,
Steg G,
Onuma Y,
Vranckx P,
Valgimigli M,
Windecker S,
Baber U,
Anderson R,
Dominici M,
Serruys P
April 3, 2020 | 10.4244/EIJ-D-19-00699
Will the Evolut Low Risk trial change my practice?
O'Sullivan C,
Reardon M,
Søndergaard L,
Treede H,
Jüni P,
Windecker S
December 20, 2019 | 10.4244/EIJ-D-19-00587
Will the PARTNER 3 Low Risk Trial change my practice?
McConkey H,
Modine T,
Latib A,
Jüni P,
Windecker S,
Leon MB
December 20, 2019 | 10.4244/EIJ-D-19-00847
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys P,
Tomaniak M,
Chichareon P,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Spitzer E,
Walsh S,
Adlam D,
Hildick-Smith D,
Édes I,
van de Harst P,
Krackhardt F,
Tijssen J,
Rademaker-Havinga T,
Garg S,
Steg G,
Hamm C,
Jüni P,
Vranckx P,
Onuma Y,
Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber CK,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg G,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology
Byrne RA,
Capodanno D,
Mahfoud F,
Fajadet J,
Windecker S,
Jüni P,
Baumbach A,
Wijns W,
Haude M
August 24, 2018 | 10.4244/EIJ-D-18-00481
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial
Iglesias JF,
Muller O,
Zaugg S,
Roffi M,
Kurz D,
Vuilliomenet A,
Weilenmann D,
Kaiser C,
Tapponnier M,
Heg D,
Valgimigli M,
Eeckhout E,
Jüni P,
Windecker S,
Pilgrim T
August 24, 2018 | 10.4244/EIJ-D-17-00734
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
Cassese S,
Byrne RA,
Jüni P,
Wykrzykowska JJ,
Puricel S,
Ndrepepa G,
Schunkert H,
Fusaro M,
Cook S,
Kimura T,
Henriques J,
Serruys P,
Windecker S,
Kastrati A
January 19, 2018 | 10.4244/EIJ-D-17-00492
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary
Byrne RA,
Stefanini G,
Capodanno D,
Onuma Y,
Baumbach A,
Escaned J,
Haude M,
James S,
Joner M,
Jüni P,
Kastrati A,
Oktay S,
Wijns W,
Serruys P,
Windecker S
January 19, 2018 | 10.4244/EIJ20170912-01
The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction
Chin C,
L’Allier P,
Neumann F,
Engstrøm T,
Jüni P,
Olivecrona G
August 4, 2017 | 10.4244/EIJV13I5A96
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis
Noble S,
Stortecky S,
Heg D,
Tueller D,
Jeger RV,
Toggweiler S,
Ferrari E,
Nietlispach F,
Taramasso M,
Maisano F,
Grünenfelder J,
Jüni P,
Huber C,
Carrel T,
Windecker S,
Wenaweser P,
Roffi M
April 7, 2017 | 10.4244/EIJ-D-16-00677
Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION
Baumbach A,
Heg D,
Räber L,
Ostoijc M,
Brugaletta S,
Strange J,
Johnson TW,
Jüni P,
Engstrøm T,
Serruys P,
Sabaté M,
Windecker S
January 20, 2017 | 10.4244/EIJ-D-15-00408
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Pilgrim T,
Piccolo R,
Heg D,
Roffi M,
Tüller D,
Vuilliomenet A,
Muller O,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Khattab A,
Taniwaki M,
Rigamonti F,
Nietlispach F,
Blochlinger S,
Wenaweser P,
Jüni P,
Windecker S
December 9, 2016 | 10.4244/EIJY15M12_09
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial
Vranckx P,
Valgimigli M,
Windecker S,
Steg G,
Hamm C,
Jüni P,
Garcia-Garcia H,
Van Es G-A,
Serruys P
November 20, 2016 | 10.4244/EIJY15M11_07
External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation
Spitzer E,
Hadorn S,
Zanchin T,
Yamaji K,
Moschovitis A,
Pilgrim T,
Stortecky S,
Jüni P,
Heg D,
Windecker S,
Räber L
October 20, 2016 | 10.4244/EIJV12I9A185
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial
Franzone A,
Taniwaki M,
Rigamonti F,
Heg D,
Piccolo R,
Roffi M,
Tüller D,
Muller O,
Vuilliomenet A,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Jüni P,
Windecker S,
Pilgrim T
August 5, 2016 | 10.4244/EIJV12I5A99
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M,
Stefanini G,
Räber L,
Brugaletta S,
Cequier A,
Heg D,
Iñiguez A,
Kelbæk H,
Serra A,
Ostojic M,
Hernández-Antolín R,
Baumbach A,
Blochlinger S,
Jüni P,
Mainar V,
Sabaté M,
Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12
1
2
3
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023